COMPOSITIONS, METHODS AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
Brazil Patent
Stats

Importance

BR Family Size
|
Non-US Coverage
|
Abstract
sal, composições, uso do referido sal, e métodos adequados à formação de um composto, para a imagiologia médica e para a detecção do transportador de norepinefrina em uma porção de um indivíduo. a presente invenção refere-se a novos métodos de síntese, sistemas, kits, sais e precursores úteis para imagiologia médica. nalgumas modalidades, a presente invenção fornece composições compreendendo um precursor de um agente de imagiologia, o qual pode ser formado usando os métodos de síntese descritos no presente documento. um agente de imagiologia pode ser convertido num agente de imagiologia usando os métodos descritos no presente documento. em alguns casos, o agente de imagiologia é enriquecido em 18f. nalguns casos, um agente de imagiologia incluindo formas salinas (por exemplo, sal de ascorbato) pode ser usado para se obter uma imagem de uma área de interesse num sujeito, incluindo, mas não se limitando a, ao coração, sistemas cardiovascular, vasos cardíacos, cérebro e outros órgãos.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
LANTHEUS MEDICAL IMAGING INC | USNORTH BILLERICA MA 01862 |
International Classification(s)

- [Classification Symbol]
- [Patents Count]
Inventor(s)
Inventor Name | Address |
---|---|
AJAY PUROHIT | 33 COUNTRY VILLAGE LANE SUDBURY MA 01776 USA |
HEIKE S RADEKE | 15 SEAVER FARM LANE SOUTH GRAFTON MA 01560 U S A |
JOEL LAZEWATSKY | US |
RICHARD R CESATI III | US |
PEDRO BENITES | US |
EDWARD H CHEESMAN | US |
RICHARD LOOBY | US |
VERONICA LEE | US |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.